Types of partnerships
Our innovative funding solutions create win-win partnerships across the biopharma ecosystem.
Existing royalties
We buy existing royalties on approved or late-stage development therapies with strong proof-of-concept to provide flexible funding solutions that align with our partners’ goals.
Synthetic royalties
We acquire newly-created royalties on approved or late-stage development therapies with strong proof-of-concept and high commercial potential.
Launch & development capital
We offer additional funding in exchange for long-term payment streams.
Facilitating M&A
We provide support to biotechnology and global pharmaceutical companies by monetizing non-strategic passive royalties to reduce the net cost of an acquisition. We also provide capital through the purchase of synthetic royalties and supplemental funding.
